Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy The ECLIPSE Trial—Interim Analysis at 1 Year Thierry de Baere, MD,

Slides:

Advertisements

Similar presentations

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Advertisements

Neoplastic Fever Caused by Lung Cancer

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Next Generation Sequencing Uncovers Potential Genetic Driver Mutations of Malignant Pulmonary Granular Cell Tumor Song Xu, Qingchun Zhao, Sen Wei, Yi.

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Lungs on Fire Journal of Thoracic Oncology

Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung Adenocarcinoma Mathilde Wagner, MD, Benjamin Besse, MD, Corinne Balleyguier, MD,

ALK FISH and IHC: You Cannot Have One without the Other

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non– Small Cell Lung Adenocarcinoma Filippo Gustavo Dall’Olio, MD, Celeste.

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

KRAS Mutation Analysis Helps to Differentiate Between Pulmonary Metastasis from Colon Adenocarcinoma In Situ and Primary Lung Adenocarcinoma Taylor M.

A Novel Strategy for Treatment of Metastatic Pulmonary Tumors: Radiofrequency Ablation in Conjunction with Surgery Yoshifumi Sano, MD, Susumu Kanazawa,

Electronic Updates for JTO Readers

Rapid Response of Brain Metastasis to Crizotinib in a Patient with ALK Rearrangement– Positive Non–Small-Cell Lung Cancer Hiroyasu Kaneda, MD, PhD, Isamu.

Complete Response Achieved 1 Year after a Single Administration of Nivolumab in a Patient with Lung Adenocarcinoma with Negative Expression of PD-L1

The Moth-Eaten Lung Journal of Thoracic Oncology

Successful Crizotinib Retreatment after Crizotinib-Induced Interstitial Lung Disease Satoru Yanagisawa, MD, PhD, Akira Inoue, MD, PhD, Akira Koarai, MD,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma Lih-Chyun Chang, MD, Kuan-Yu Chen, MD, PhD, Jin-Yuan.

Dramatic Response to Pemetrexed in a Patient with Pneumonic-Type Mucinous Bronchioloalveolar Carcinoma David H. Garfield, MD, Wilbur Franklin, MD Journal.

Nikolaas De Maeyer, MD, Walter De Wever, MD, PhD, Christophe M

Neoplastic Fever Caused by Lung Cancer

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

A Severe Photosensitivity Dermatitis Caused by Crizotinib

Multiple Pulmonary Chondroid Hamartoma

Follow-Up of Patients after Stereotactic Radiation for Lung Cancer: A Primer for the Nonradiation Oncologist Kitty Huang, MSc, MDCM, David A. Palma,

Impact of Positive Nodal Metastases in Patients with Thymic Carcinoma and Thymic Neuroendocrine Tumors Benny Weksler, MD, Anthony Holden, MD, Jennifer.

Disease Flare After Treatment Discontinuation in a Patient With EML4-ALK Lung Cancer and Acquired Resistance to Crizotinib Oana Pop, MD, Augustin Pirvu,

Socioeconomic Status Is Associated with Depressive Severity Among Patients with Advanced Non–Small-Cell Lung Cancer: Treatment Setting and Minority Status.

In This Issue Journal of Thoracic Oncology

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

Choroidal Metastases Responsive to Crizotinib Therapy in a Lung Adenocarcinoma Patient with ALK 2p23 Fusion Identified by ALK Immunohistochemistry Yan.

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller Yangki Seok,

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Osteoblastic Bone Lesions Developing During Treatment with Erlotinib Indicate Major Response in Patients with Non-small Cell Lung Cancer: A Brief Report

A Case of Nontuberculous Mycobacteria Highly Suspected as Lung Cancer Invading the Aortic Arch Tadashi Umehara, MD, Masaya Aoki, MD, PhD, Aya Harada,

Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma Naoyuki.

Mirror Mirror on the Wall, Who Is the Fairest of Them All

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer Allison Ackerman, MD, Michael A. Goldstein,

Drug Interaction Between Complementary Herbal Medicines and Gefitinib

S768I Mutation in EGFR in Patients with Lung Cancer

Multiple Pulmonary Nodules in an Elderly Woman

Phase I Study of Lenalidomide in Solid Tumors

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Two Generations of Light/Never-Smokers With Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib Nathan A. Pennell, MD, PhD, Lihong.

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Metastatic Lung Cancer to the Pancreas

S-1 Treatment for Chemorefractory Thymic Carcinoma

Follow-Up of Small (4 mm or Less) Incidentally Detected Nodules by Computed Tomography in Oncology Patients: A Retrospective Review Reginald F. Munden,

Collaterals Journal of Thoracic Oncology

Philip A. Linden, MD, Jon O. Wee, MD, Michael T

Intrathoracic Desmoid Tumor: Brief Report and Review of Literature

Todd J. Carpenter, MD, Kenneth E. Rosenzweig, MD

Cristiano Rampinelli, MD, Vittoria Vecchi, MD, Massimo Bellomi, MD

Journal of Thoracic Oncology

IASLC 6th Latin American Conference on Lung Cancer

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

David Garfield, MD Journal of Thoracic Oncology

Popcorn in the Lung Journal of Thoracic Oncology

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

Adding Bevacizumab to Chemotherapy Effectively Control Radioresistant Brain Metastases in ALK-Positive Lung Adenocarcinoma Yu-Li Su, MD Journal of Thoracic.

Patterns-of-Care for Thoracic Stereotactic Body Radiotherapy among Practicing Radiation Oncologists in the United States Megan E. Daly, MD, Julian R.

Miliary Brain Metastases in a Patient with ROS1-Rearranged Lung Adenocarcinoma: A Case Report Katarzyna Dziadziuszko, MD, Edyta Szurowska, MD, PhD, Joanna.

Ana Luque, MD, Edurne Arriola, MD, PhD Journal of Thoracic Oncology

Presentation transcript:

Evaluating Cryoablation of Metastatic Lung Tumors in Patients—Safety and Efficacy The ECLIPSE Trial—Interim Analysis at 1 Year Thierry de Baere, MD, Lambros Tselikas, MD, David Woodrum, MD, PhD, Fereidoun Abtin, MD, Peter Littrup, MD, Frederic Deschamps, MD, Robert Suh, MD, Hussein D. Aoun, MD, Matthew Callstrom, MD, PhD Journal of Thoracic Oncology Volume 10, Issue 10, Pages 1468-1474 (October 2015) DOI: 10.1097/JTO.0000000000000632 Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Percutaneous cryoablation under computed tomography (CT)-scan guidance. CT-scan images of the chest without contrast obtained before (A and B) and during (C and D) the cryoablation from a 71-year-old patient with right lower lobe lung metastases from a colon adenocarcinoma. Journal of Thoracic Oncology 2015 10, 1468-1474DOI: (10.1097/JTO.0000000000000632) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Follow-up after percutaneous cryoablation. Follow-up computed tomography (CT)-scans performed at 3 months (A and B), 6 months (C and D), and 1 year (E and F) after the cryoablation procedure showing a resorption of the ablation zone (same patient as Fig. 1). Journal of Thoracic Oncology 2015 10, 1468-1474DOI: (10.1097/JTO.0000000000000632) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Tumor size evolution graph during 1-year follow-up. Journal of Thoracic Oncology 2015 10, 1468-1474DOI: (10.1097/JTO.0000000000000632) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions